Our Blogs

$166 Billion in Tariff Refunds, and What It Quietly Reveals About the US Market

In an Uncertain World, One Market Still Stands Strong: Why the US Remains the Most Strategic Expansion Choice for Indian Businesses

Why Businesses Continue to Expand to the U.S. During Geopolitical Uncertainty

Entering the U.S. Market: What Indian Businesses Must Get Right Before They Expand

How Do I Know If My Business Is Ready for the U.S. Market?

Why Now Is the Moment to Enter the U.S.

India–US Trade Is Accelerating. Are You Positioned?

Lower U.S. Tariffs, Bigger Opportunities for Indian Businesses

India–US Relations Are Opening New Business Doors

US Financial Reporting Compliance Requirements for Indian Pharmaceutical Firms

How Lack of US Tax Planning Reduces Profit Margins for Indian Pharmaceutical Companies

How Indam Advisors Helps Pharma Companies Draft US Contracts and Agreements Without Errors

US FDA Requirements for Indian Pharma Companies: What Approvals Are Needed to Sell in the USA?

How Pharmaceutical Companies Can Protect Their Innovations When Expanding to the U.S. 

Legal & Tax Essentials for Solar Business Expansion in the U.S. Renewable Energy Market

LLC vs. C-Corp: The Ultimate US Business Structure Tax Planning Showdown

Register Your Indian Business in the USA: A Step-by-Step Process with Indam Advisors

Impact of India’s New Foreign Trade Policy on U.S. Market Access

Cross-Border Tax Audits: How Indian Businesses Can Prepare for U.S. Tax Authorities

Recent Indian GST Amendments and Their Impact on Export-Oriented Businesses